메뉴 건너뛰기




Volumn 41, Issue 9, 2011, Pages 1196-1199

Topoisomerase i expression in tumors as a biological marker for CPT-11 chemosensitivity in patients with colorectal cancer

Author keywords

Chemosensitivity; Colorectal cancer; DNA topoisomerase I; Immunohistochemistry

Indexed keywords

DNA TOPOISOMERASE; FLUOROURACIL; IRINOTECAN; TUMOR MARKER; UFT;

EID: 80052413958     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-011-4546-7     Document Type: Review
Times cited : (39)

References (46)
  • 1
    • 78349300163 scopus 로고    scopus 로고
    • Curative surgery improves the survival of patients with perforating colorectal cancer
    • 21046503 10.1007/s00595-009-4155-x
    • K. Shibahara H. Orita T. Koga H. Kohno H. Sakata Y. Kakeji, et al. 2010 Curative surgery improves the survival of patients with perforating colorectal cancer Surg Today 40 1046 1049 21046503 10.1007/s00595-009-4155-x
    • (2010) Surg Today , vol.40 , pp. 1046-1049
    • Shibahara, K.1    Orita, H.2    Koga, T.3    Kohno, H.4    Sakata, H.5    Kakeji, Y.6
  • 2
    • 76849110838 scopus 로고    scopus 로고
    • Long-term results of laparoscopic colorectal cancer resection: Current knowledge and what remains unclear
    • 20107946 10.1007/s00595-009-4133-3
    • K.Y. Tan F. Konishi 2010 Long-term results of laparoscopic colorectal cancer resection: current knowledge and what remains unclear Surg Today 40 97 101 20107946 10.1007/s00595-009-4133-3
    • (2010) Surg Today , vol.40 , pp. 97-101
    • Tan, K.Y.1    Konishi, F.2
  • 3
    • 0034712536 scopus 로고    scopus 로고
    • Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial
    • 10744089 10.1016/S0140-6736(00)02034-1 1:CAS:528:DC%2BD3cXisFOnsb4%3D
    • J.Y. Douillard D. Cunningham A.D. Roth M. Navarro R.D. James P. Karasek, et al. 2000 Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial Lancet 355 1041 1047 10744089 10.1016/S0140-6736(00)02034-1 1:CAS:528:DC%2BD3cXisFOnsb4%3D
    • (2000) Lancet , vol.355 , pp. 1041-1047
    • Douillard, J.Y.1    Cunningham, D.2    Roth, A.D.3    Navarro, M.4    James, R.D.5    Karasek, P.6
  • 4
    • 0033874892 scopus 로고    scopus 로고
    • Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
    • 10944126
    • A. de Gramont A. Figer M. Seymour M. Homerin A. Hmissi J. Cassidy, et al. 2000 Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2938 2947 10944126
    • (2000) J Clin Oncol , vol.18 , pp. 2938-2947
    • De Gramont, A.1    Figer, A.2    Seymour, M.3    Homerin, M.4    Hmissi, A.5    Cassidy, J.6
  • 5
    • 1842569206 scopus 로고    scopus 로고
    • A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
    • 14665611 10.1200/JCO.2004.09.046 1:CAS:528:DC%2BD2cXpsVKitbY%3D
    • R.M. Goldberg D.J. Sargent R.F. Morton R.F. Morton C.S. Fuchs R.K. Ramanathan, et al. 2004 A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer J Clin Oncol 22 23 30 14665611 10.1200/JCO.2004.09.046 1:CAS:528:DC%2BD2cXpsVKitbY%3D
    • (2004) J Clin Oncol , vol.22 , pp. 23-30
    • Goldberg, R.M.1    Sargent, D.J.2    Morton, R.F.3    Morton, R.F.4    Fuchs, C.S.5    Ramanathan, R.K.6
  • 6
    • 1342290189 scopus 로고    scopus 로고
    • FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study
    • 14657227 10.1200/JCO.2004.05.113 1:CAS:528:DC%2BD2cXpsVKit7w%3D
    • C. Tournigand T. André E. Achille G. Lledo M. Flesh D. Mery-Mignard, et al. 2004 FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study J Clin Oncol 22 229 237 14657227 10.1200/JCO.2004.05.113 1:CAS:528:DC%2BD2cXpsVKit7w%3D
    • (2004) J Clin Oncol , vol.22 , pp. 229-237
    • Tournigand, C.1    André, T.2    Achille, E.3    Lledo, G.4    Flesh, M.5    Mery-Mignard, D.6
  • 7
    • 3142660249 scopus 로고    scopus 로고
    • Topoisomerase-I, thymidylate synthase primary tumour expression and clinical efficacy of 5-FU/CPT-11 chemotherapy in advanced colorectal cancer patients
    • 15197779 10.1002/ijc.20208 1:CAS:528:DC%2BD2cXlvFWnsbw%3D
    • A. Paradiso J. Xu A. Mangia A. Chiriatti G. Simone A. Zito, et al. 2004 Topoisomerase-I, thymidylate synthase primary tumour expression and clinical efficacy of 5-FU/CPT-11 chemotherapy in advanced colorectal cancer patients Int J Cancer 111 252 258 15197779 10.1002/ijc.20208 1:CAS:528:DC%2BD2cXlvFWnsbw%3D
    • (2004) Int J Cancer , vol.111 , pp. 252-258
    • Paradiso, A.1    Xu, J.2    Mangia, A.3    Chiriatti, A.4    Simone, G.5    Zito, A.6
  • 9
    • 0142157104 scopus 로고    scopus 로고
    • Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis
    • 14581373 1:CAS:528:DC%2BD3sXosVGjtb4%3D
    • S.P. Sanghani S.K. Quinney T.B. Fredenburg Z. Sun W.I. Davis D.J. Murry, et al. 2003 Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis Clin Cancer Res 9 4983 4991 14581373 1:CAS:528:DC%2BD3sXosVGjtb4%3D
    • (2003) Clin Cancer Res , vol.9 , pp. 4983-4991
    • Sanghani, S.P.1    Quinney, S.K.2    Fredenburg, T.B.3    Sun, Z.4    Davis, W.I.5    Murry, D.J.6
  • 10
    • 0034712536 scopus 로고    scopus 로고
    • Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial
    • 10744089 10.1016/S0140-6736(00)02034-1 1:CAS:528:DC%2BD3cXisFOnsb4%3D
    • J.Y. Douillard D. Cunningham A.D. Roth M. Navarro R.D. James P. Karasek, et al. 2000 Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial Lancet 355 1041 1047 10744089 10.1016/S0140-6736(00)02034-1 1:CAS:528:DC%2BD3cXisFOnsb4%3D
    • (2000) Lancet , vol.355 , pp. 1041-1047
    • Douillard, J.Y.1    Cunningham, D.2    Roth, A.D.3    Navarro, M.4    James, R.D.5    Karasek, P.6
  • 11
    • 0034727063 scopus 로고    scopus 로고
    • Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer
    • 11006366 10.1056/NEJM200009283431302 1:CAS:528:DC%2BD3cXntFOkt7Y%3D
    • L.B. Saltz J.V. Cox C. Blanke L.S. Rosen L. Fehrenbacher M.J. Moore, et al. 2000 Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer N Engl J Med 343 905 914 11006366 10.1056/NEJM200009283431302 1:CAS:528:DC%2BD3cXntFOkt7Y%3D
    • (2000) N Engl J Med , vol.343 , pp. 905-914
    • Saltz, L.B.1    Cox, J.V.2    Blanke, C.3    Rosen, L.S.4    Fehrenbacher, L.5    Moore, M.J.6
  • 13
    • 0028006314 scopus 로고
    • Elevation of topoisomerase i messenger RNA, protein, and catalytic activity in human tumors: Demonstration of tumor-type specificity and implications for cancer chemotherapy
    • 8275492 1:CAS:528:DyaK2cXhs1Sgsrc%3D
    • I. Husain J.L. Mohler H.F. Seigler J.M. Besterman 1994 Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy Cancer Res 54 539 546 8275492 1:CAS:528:DyaK2cXhs1Sgsrc%3D
    • (1994) Cancer Res , vol.54 , pp. 539-546
    • Husain, I.1    Mohler, J.L.2    Seigler, H.F.3    Besterman, J.M.4
  • 14
    • 0028090410 scopus 로고
    • Phase i and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemia
    • 7931489 1:STN:280:DyaK2M%2Fhs1yrtA%3D%3D
    • E.K. Rowinsky A. Adjei R.C. Donehower S.D. Gore R.J. Jones P.J. Burke, et al. 1994 Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemia J Clin Oncol 12 2193 2203 7931489 1:STN:280:DyaK2M%2Fhs1yrtA%3D%3D
    • (1994) J Clin Oncol , vol.12 , pp. 2193-2203
    • Rowinsky, E.K.1    Adjei, A.2    Donehower, R.C.3    Gore, S.D.4    Jones, R.J.5    Burke, P.J.6
  • 15
    • 0027979432 scopus 로고
    • Quantitative and qualitative aspects of topoisomerase i and II alpha and beta in untreated and platinum/cyclophosphamide treated malignant ovarian tumors
    • 8306337
    • A.G. van der Zee S. de Jong W.N. Keith H. Hollema H. Boonstra E.G. de Vries 1994 Quantitative and qualitative aspects of topoisomerase I and II alpha and beta in untreated and platinum/cyclophosphamide treated malignant ovarian tumors Cancer Res 54 749 755 8306337
    • (1994) Cancer Res , vol.54 , pp. 749-755
    • Van Der Zee, A.G.1    De Jong, S.2    Keith, W.N.3    Hollema, H.4    Boonstra, H.5    De Vries, E.G.6
  • 17
    • 0032169909 scopus 로고    scopus 로고
    • Camptothecins: A review of their development and schedules of administration
    • 9893620 10.1016/S0959-8049(98)00229-9
    • J. O'Leary F.M. Muggia 1998 Camptothecins: a review of their development and schedules of administration Eur J Cancer 34 1500 1508 9893620 10.1016/S0959-8049(98)00229-9
    • (1998) Eur J Cancer , vol.34 , pp. 1500-1508
    • O'Leary, J.1    Muggia, F.M.2
  • 18
    • 0029029436 scopus 로고
    • Topoisomerase I-related parameters and camptothecin activity in the colon carcinoma cell lines from the National Center Institute and anticancer screen
    • F. Goldwassew I. Bae M. Valenti K. Torres Y. Pommier 1995 Topoisomerase I-related parameters and camptothecin activity in the colon carcinoma cell lines from the National Center Institute and anticancer screen Cancer Res 55 2116 2121
    • (1995) Cancer Res , vol.55 , pp. 2116-2121
    • Goldwassew, F.1    Bae, I.2    Valenti, M.3    Torres, K.4    Pommier, Y.5
  • 19
    • 0024420685 scopus 로고
    • Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin
    • 2548710 1:CAS:528:DyaL1MXls1KqsLs%3D
    • Y. Hsiang M.G. Lihou L.F. Liu 1989 Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin Cancer Res 49 5077 5082 2548710 1:CAS:528: DyaL1MXls1KqsLs%3D
    • (1989) Cancer Res , vol.49 , pp. 5077-5082
    • Hsiang, Y.1    Lihou, M.G.2    Liu, L.F.3
  • 20
    • 0344394180 scopus 로고    scopus 로고
    • Mechanisms of resistance to topoisomerase I-targeting drugs
    • 14576839 10.1038/sj.onc.1206935 1:CAS:528:DC%2BD3sXotlajur4%3D
    • Z.A. Rasheed E.H. Rubin 2003 Mechanisms of resistance to topoisomerase I-targeting drugs Oncogene 22 7296 7304 14576839 10.1038/sj.onc.1206935 1:CAS:528:DC%2BD3sXotlajur4%3D
    • (2003) Oncogene , vol.22 , pp. 7296-7304
    • Rasheed, Z.A.1    Rubin, E.H.2
  • 21
    • 0025151823 scopus 로고
    • Decreased expression of DNA topoisomerase i in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody
    • 2170010 1:CAS:528:DyaK3cXmt1ChtL0%3D
    • Y. Sugimoto S. Tsukahara T. Oh-hara T. Isoe T. Tsuruo 1990 Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody Cancer Res 50 6925 6930 2170010 1:CAS:528:DyaK3cXmt1ChtL0%3D
    • (1990) Cancer Res , vol.50 , pp. 6925-6930
    • Sugimoto, Y.1    Tsukahara, S.2    Oh-Hara, T.3    Isoe, T.4    Tsuruo, T.5
  • 22
    • 0027005977 scopus 로고
    • Camptothecin hyper-resistant P388 cells: Drug-dependent reduction in topoisomerase i content
    • 1338578 1:CAS:528:DyaK3sXkvVGmtbo%3D
    • R.D. Woessner W.K. Eng G.A. Hofmann D.J. Rieman F.L. McCabe R.P. Hertzberg, et al. 1992 Camptothecin hyper-resistant P388 cells: drug-dependent reduction in topoisomerase I content Oncol Res 4 481 488 1338578 1:CAS:528:DyaK3sXkvVGmtbo%3D
    • (1992) Oncol Res , vol.4 , pp. 481-488
    • Woessner, R.D.1    Eng, W.K.2    Hofmann, G.A.3    Rieman, D.J.4    McCabe, F.L.5    Hertzberg, R.P.6
  • 23
    • 0030661729 scopus 로고    scopus 로고
    • Immunohistochemical detection of DNA topoisomerase i in formalin fixed, paraffin wax embedded normal tissues and in ovarian carcinoma
    • 10.1136/mp.50.5.247 1:CAS:528:DyaK2sXntl2jur4%3D
    • J.A. Holden M.P. Rahn C.J. Jolles S.V. Vorobyev I.B. Bronstein 1997 Immunohistochemical detection of DNA topoisomerase I in formalin fixed, paraffin wax embedded normal tissues and in ovarian carcinoma J Clin Pathol 50 247 153 10.1136/mp.50.5.247 1:CAS:528:DyaK2sXntl2jur4%3D
    • (1997) J Clin Pathol , vol.50 , pp. 247-153
    • Holden, J.A.1    Rahn, M.P.2    Jolles, C.J.3    Vorobyev, S.V.4    Bronstein, I.B.5
  • 24
    • 40749109040 scopus 로고    scopus 로고
    • Topoisomerase i protein expression and prognosis of patients with colorectal cancer
    • M. Ataka M. Ikeguchi M. Yamamoto M. Inoue T. Tanida S. Oka, et al. 2007 Topoisomerase I protein expression and prognosis of patients with colorectal cancer Yonago Acta Medica 50 81 87
    • (2007) Yonago Acta Medica , vol.50 , pp. 81-87
    • Ataka, M.1    Ikeguchi, M.2    Yamamoto, M.3    Inoue, M.4    Tanida, T.5    Oka, S.6
  • 25
    • 0030939518 scopus 로고    scopus 로고
    • Differential immunohistochemical staining for DNA topoisomerase IIα and β in human tissues and for DNA topoisomerase IIβ in non-Hodgkin's lymphomas
    • 1:STN:280:DyaK2s3isFenuw%3D%3D
    • M.E. Bauman J.A. Holden K.A. Brown W.G. Harker S.L. Perkins 1997 Differential immunohistochemical staining for DNA topoisomerase IIα and β in human tissues and for DNA topoisomerase IIβ in non-Hodgkin's lymphomas Mod Pathol 1 10 168 175 1:STN:280:DyaK2s3isFenuw%3D%3D
    • (1997) Mod Pathol 1 , vol.10 , pp. 168-175
    • Bauman, M.E.1    Holden, J.A.2    Brown, K.A.3    Harker, W.G.4    Perkins, S.L.5
  • 26
    • 3042766238 scopus 로고    scopus 로고
    • Immunohistochemical study of DNA topoisomerase I, DNA topoisomerase IIα, p53, and Ki-67 in oral preneoplastic lesions and oral squamous cell carcinomas
    • 10.1016/j.humpath.2004.02.004 1:CAS:528:DC%2BD2cXkslWls70%3D
    • H. Hafian L. Venteo A. Sukhanova I. Nabiev B. Lefevre M. Pluot 2004 Immunohistochemical study of DNA topoisomerase I, DNA topoisomerase IIα, p53, and Ki-67 in oral preneoplastic lesions and oral squamous cell carcinomas Hum Pathol 2 35 745 751 10.1016/j.humpath.2004.02.004 1:CAS:528: DC%2BD2cXkslWls70%3D
    • (2004) Hum Pathol 2 , vol.35 , pp. 745-751
    • Hafian, H.1    Venteo, L.2    Sukhanova, A.3    Nabiev, I.4    Lefevre, B.5    Pluot, M.6
  • 27
    • 0033623883 scopus 로고    scopus 로고
    • Expression of DNA topoisomerase i and DNA topoisomerase II-alpha in testicular seminomas
    • 10872667 10.1053/hupa.2000.8462 1:CAS:528:DC%2BD3cXksVGhtb0%3D
    • L.W. Coleman S.L. Perkins I.B. Bronstein J.A. Holden 2000 Expression of DNA topoisomerase I and DNA topoisomerase II-alpha in testicular seminomas Hum Pathol 31 728 733 10872667 10.1053/hupa.2000.8462 1:CAS:528:DC%2BD3cXksVGhtb0%3D
    • (2000) Hum Pathol , vol.31 , pp. 728-733
    • Coleman, L.W.1    Perkins, S.L.2    Bronstein, I.B.3    Holden, J.A.4
  • 28
    • 0033966889 scopus 로고    scopus 로고
    • Expression of DNA topoisomerase i in neoplasms of the kidney: Correlation with histological grade, proliferation, and patient survival
    • 10685636 10.1016/S0046-8177(00)80222-1 1:CAS:528:DC%2BD3cXhsV2ju70%3D
    • D. Gupta I.B. Bronstein J.A. Holden 2000 Expression of DNA topoisomerase I in neoplasms of the kidney: correlation with histological grade, proliferation, and patient survival Hum Pathol 31 214 219 10685636 10.1016/S0046-8177(00)80222-1 1:CAS:528:DC%2BD3cXhsV2ju70%3D
    • (2000) Hum Pathol , vol.31 , pp. 214-219
    • Gupta, D.1    Bronstein, I.B.2    Holden, J.A.3
  • 29
    • 0035013497 scopus 로고    scopus 로고
    • Immunohistochemical staining for DNA topoisomerase I, DNA topoisomerase II-alpha and p53 in gastric carcinomas
    • 11396158 1:CAS:528:DC%2BD3MXksVOjtL0%3D
    • L.W. Coleman I.B. Bronstein J.A. Holden 2001 Immunohistochemical staining for DNA topoisomerase I, DNA topoisomerase II-alpha and p53 in gastric carcinomas Anticancer Res 21 1167 1172 11396158 1:CAS:528:DC%2BD3MXksVOjtL0%3D
    • (2001) Anticancer Res , vol.21 , pp. 1167-1172
    • Coleman, L.W.1    Bronstein, I.B.2    Holden, J.A.3
  • 30
    • 0034943945 scopus 로고    scopus 로고
    • Elevations of DNA topoisomerase i in invasive carcinomas of the breast
    • 11469931 10.1046/j.1524-4741.2001.007003176.x 1:STN:280: DC%2BD38%2FitFWqsA%3D%3D
    • B.J. Lynch I.B. Bronstein J.A. Holden 2001 Elevations of DNA topoisomerase I in invasive carcinomas of the breast Breast J 7 176 180 11469931 10.1046/j.1524-4741.2001.007003176.x 1:STN:280:DC%2BD38%2FitFWqsA%3D%3D
    • (2001) Breast J , vol.7 , pp. 176-180
    • Lynch, B.J.1    Bronstein, I.B.2    Holden, J.A.3
  • 31
    • 0036858423 scopus 로고    scopus 로고
    • Topoisomerase i protein expression in primary colorectal cancer and lymph node metastases
    • 12454816 10.1053/hupa.2002.129202 1:CAS:528:DC%2BD38Xps1Gku7s%3D
    • A. Boonsong S. Curran J.A. McKay J. Cassidy G.I. Murray H.L. McLeod 2002 Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases Hum Pathol 33 1114 1119 12454816 10.1053/hupa.2002.129202 1:CAS:528:DC%2BD38Xps1Gku7s%3D
    • (2002) Hum Pathol , vol.33 , pp. 1114-1119
    • Boonsong, A.1    Curran, S.2    McKay, J.A.3    Cassidy, J.4    Murray, G.I.5    McLeod, H.L.6
  • 32
    • 70449360930 scopus 로고    scopus 로고
    • Topoisomerase i but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy
    • 19775480 10.1186/1471-2407-9-339
    • I. Kostopoulos V. Karavasilis M. Karina M. Bobos N. Xiros G. Pentheroudakis, et al. 2009 Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy BMC Cancer 9 339 19775480 10.1186/1471-2407-9-339
    • (2009) BMC Cancer , vol.9 , pp. 339
    • Kostopoulos, I.1    Karavasilis, V.2    Karina, M.3    Bobos, M.4    Xiros, N.5    Pentheroudakis, G.6
  • 33
    • 0036321137 scopus 로고    scopus 로고
    • Human DNA topoisomerase I: An anticancer drug target present in human sarcomas
    • 12152158 10.1053/hupa.2002.124911 1:CAS:528:DC%2BD38Xms1Sis74%3D
    • L.W. Coleman L.R. Rohr I.B. Bronstein J.A. Holden 2002 Human DNA topoisomerase I: an anticancer drug target present in human sarcomas Hum Pathol 33 599 607 12152158 10.1053/hupa.2002.124911 1:CAS:528:DC%2BD38Xms1Sis74%3D
    • (2002) Hum Pathol , vol.33 , pp. 599-607
    • Coleman, L.W.1    Rohr, L.R.2    Bronstein, I.B.3    Holden, J.A.4
  • 34
    • 0032932111 scopus 로고    scopus 로고
    • Expression of DNA topoisomerase i and DNA topoisomerase II-alpha in carcinoma of the colon
    • 10229499 1:STN:280:DyaK1M3ksVGjtw%3D%3D
    • B.E. Staley W.S. Samowitz I.B. Bronstein J.A. Holden 1999 Expression of DNA topoisomerase I and DNA topoisomerase II-alpha in carcinoma of the colon Mod Pathol 12 356 361 10229499 1:STN:280:DyaK1M3ksVGjtw%3D%3D
    • (1999) Mod Pathol , vol.12 , pp. 356-361
    • Staley, B.E.1    Samowitz, W.S.2    Bronstein, I.B.3    Holden, J.A.4
  • 35
    • 0029758307 scopus 로고    scopus 로고
    • Variation in topoisomerase i gene copy number as a mechanism for intrinsic drug sensitivity
    • 8761363 10.1038/bjc.1996.394 1:CAS:528:DyaK28XlvVWjtro%3D
    • H.L. McLeod W.N. Keith 1996 Variation in topoisomerase I gene copy number as a mechanism for intrinsic drug sensitivity Br J Cancer 74 508 512 8761363 10.1038/bjc.1996.394 1:CAS:528:DyaK28XlvVWjtro%3D
    • (1996) Br J Cancer , vol.74 , pp. 508-512
    • McLeod, H.L.1    Keith, W.N.2
  • 36
    • 0031046059 scopus 로고    scopus 로고
    • CPT-11 in human colon-cancer cell lines and xenografts: Characterization of cellular sensitivity determinants
    • 9033637 10.1002/(SICI)1097-0215(19970127)70:3<335::AID-IJC15>3.0. CO;2-E 1:CAS:528:DyaK2sXhs1Omsr8%3D
    • W.J. Jansen B. Zwart S.T. Hulscher G. Giaccone H.M. Pinedo E. Boven 1997 CPT-11 in human colon-cancer cell lines and xenografts: characterization of cellular sensitivity determinants Int J Cancer 70 335 340 9033637 10.1002/(SICI)1097-0215(19970127)70:3<335::AID-IJC15>3.0.CO;2-E 1:CAS:528:DyaK2sXhs1Omsr8%3D
    • (1997) Int J Cancer , vol.70 , pp. 335-340
    • Jansen, W.J.1    Zwart, B.2    Hulscher, S.T.3    Giaccone, G.4    Pinedo, H.M.5    Boven, E.6
  • 37
    • 6344237103 scopus 로고    scopus 로고
    • ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastasis
    • 15027118 10.1002/ijc.20032 1:CAS:528:DC%2BD2cXjt1ensrc%3D
    • L. Candeil I. Gourdier D. Peyron N. Vezzio V. Copois F. Bibeau, et al. 2004 ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastasis Int J Cancer 109 848 854 15027118 10.1002/ijc.20032 1:CAS:528:DC%2BD2cXjt1ensrc%3D
    • (2004) Int J Cancer , vol.109 , pp. 848-854
    • Candeil, L.1    Gourdier, I.2    Peyron, D.3    Vezzio, N.4    Copois, V.5    Bibeau, F.6
  • 38
    • 0042343743 scopus 로고    scopus 로고
    • Carboxylesterase-mediated sensitization of human tumor cells to CPT-11 cannot override ABCG2-mediated drug resistance
    • 12869632 10.1124/mol.64.2.279 1:CAS:528:DC%2BD3sXlvVCnsrk%3D
    • M. Wierdl A. Wall C.L. Morton J. Sampath M.K. Danks J.D. Schuetz, et al. 2003 Carboxylesterase-mediated sensitization of human tumor cells to CPT-11 cannot override ABCG2-mediated drug resistance Mol Pharmacol 64 279 288 12869632 10.1124/mol.64.2.279 1:CAS:528:DC%2BD3sXlvVCnsrk%3D
    • (2003) Mol Pharmacol , vol.64 , pp. 279-288
    • Wierdl, M.1    Wall, A.2    Morton, C.L.3    Sampath, J.4    Danks, M.K.5    Schuetz, J.D.6
  • 39
    • 0142157104 scopus 로고    scopus 로고
    • Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis
    • 14581373 1:CAS:528:DC%2BD3sXosVGjtb4%3D
    • S.P. Sanghani S.K. Quinney T.B. Fredenburg Z. Sun W.I. Davis D.J. Murry, et al. 2003 Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis Clin Cancer Res 9 4983 49891 14581373 1:CAS:528:DC%2BD3sXosVGjtb4%3D
    • (2003) Clin Cancer Res , vol.9 , pp. 4983-49891
    • Sanghani, S.P.1    Quinney, S.K.2    Fredenburg, T.B.3    Sun, Z.4    Davis, W.I.5    Murry, D.J.6
  • 40
    • 0036206897 scopus 로고    scopus 로고
    • Determinants of cytotoxicity of irinotecan in two human colorectal tumor cell lines
    • 11914913 10.1007/s00280-001-0416-0 1:CAS:528:DC%2BD38XitFeiur0%3D
    • V. Pavillard C. Agostini S. Richard V. Charasson D. Montaudon J. Robert 2002 Determinants of cytotoxicity of irinotecan in two human colorectal tumor cell lines Cancer Chemother Pharmacol 49 329 335 11914913 10.1007/s00280-001- 0416-0 1:CAS:528:DC%2BD38XitFeiur0%3D
    • (2002) Cancer Chemother Pharmacol , vol.49 , pp. 329-335
    • Pavillard, V.1    Agostini, C.2    Richard, S.3    Charasson, V.4    Montaudon, D.5    Robert, J.6
  • 42
    • 0035570120 scopus 로고    scopus 로고
    • The prognostic significance of proliferative activity, apoptosis and expression of DNA topoisomerase II alpha in multimodally-treated oesophageal squamous cell carcinoma
    • 11848536 1:CAS:528:DC%2BD38XhvFGmtr0%3D
    • M. Rees M. Stahl B. Klump R. Willers H.E. Gabbert M. Sarbia 2001 The prognostic significance of proliferative activity, apoptosis and expression of DNA topoisomerase II alpha in multimodally-treated oesophageal squamous cell carcinoma Anticancer Res 21 3637 3642 11848536 1:CAS:528:DC%2BD38XhvFGmtr0%3D
    • (2001) Anticancer Res , vol.21 , pp. 3637-3642
    • Rees, M.1    Stahl, M.2    Klump, B.3    Willers, R.4    Gabbert, H.E.5    Sarbia, M.6
  • 43
    • 33748676715 scopus 로고    scopus 로고
    • Chemotherapy may be more effective in highly proliferative ovarian carcinomas - A translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol)
    • 10.1016/j.ygyno.2006.01.037
    • S. Kommossa A. du Boisb D. Schmidta R. Parwaresch J. Pfisterer F. Kommoss 2006 Chemotherapy may be more effective in highly proliferative ovarian carcinomas - a translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol) Gynecol Oncol 103 67 71 10.1016/j.ygyno.2006.01.037
    • (2006) Gynecol Oncol , vol.103 , pp. 67-71
    • Kommossa, S.1    Du Boisb, A.2    Schmidta, D.3    Parwaresch, R.4    Pfisterer, J.5    Kommoss, F.6
  • 44
    • 35248873324 scopus 로고    scopus 로고
    • Topoisomerase i protein expression in primary colorectal cancer and recurrence after 5-FU-based adjuvant chemotherapy
    • 17605046 10.1007/s00432-007-0253-6 1:CAS:528:DC%2BD2sXhtFChu7nP
    • P. Gouveris A.C. Lazaris T.G. Papathomas A. Nonni V. Kyriakou J. Delladetsima, et al. 2007 Topoisomerase I protein expression in primary colorectal cancer and recurrence after 5-FU-based adjuvant chemotherapy J Cancer Res Clin Oncol 133 1011 1015 17605046 10.1007/s00432-007-0253-6 1:CAS:528:DC%2BD2sXhtFChu7nP
    • (2007) J Cancer Res Clin Oncol , vol.133 , pp. 1011-1015
    • Gouveris, P.1    Lazaris, A.C.2    Papathomas, T.G.3    Nonni, A.4    Kyriakou, V.5    Delladetsima, J.6
  • 45
    • 66949178721 scopus 로고    scopus 로고
    • Topoisomerase i and IIα protein expression in primary colorectal cancer and recurrence following 5- fluorouracil-based adjuvant chemotherapy
    • 10.1007/s00280-008-0886-4 1:CAS:528:DC%2BD1MXms1agu7w%3D
    • N. Tsavaris A. Lazaris C. Kosmas P. Gouveris N. Kavantzas P. Kopterides, et al. 2009 Topoisomerase I and IIα protein expression in primary colorectal cancer and recurrence following 5- fluorouracil-based adjuvant chemotherapy Cancer Chemother Pharmacol 2 64 391 398 10.1007/s00280-008-0886-4 1:CAS:528:DC%2BD1MXms1agu7w%3D
    • (2009) Cancer Chemother Pharmacol 2 , vol.64 , pp. 391-398
    • Tsavaris, N.1    Lazaris, A.2    Kosmas, C.3    Gouveris, P.4    Kavantzas, N.5    Kopterides, P.6
  • 46
    • 77951010997 scopus 로고    scopus 로고
    • Aprataxin tumor levels predict response of colorectal cancer patients to irinotecan-based treatment
    • 20371676 10.1158/1078-0432.CCR-09-3275 1:CAS:528:DC%2BC3cXkslSlsrk%3D
    • H. Dopeso S. Mateo-Lozano E. Elez S. Landolfi F.J.R. Pascual J. Hernandez-Losa, et al. 2010 Aprataxin tumor levels predict response of colorectal cancer patients to irinotecan-based treatment Clin Cancer Res 16 2375 2382 20371676 10.1158/1078-0432.CCR-09-3275 1:CAS:528:DC%2BC3cXkslSlsrk%3D
    • (2010) Clin Cancer Res , vol.16 , pp. 2375-2382
    • Dopeso, H.1    Mateo-Lozano, S.2    Elez, E.3    Landolfi, S.4    Pascual, F.J.R.5    Hernandez-Losa, J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.